Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study

Objective To evaluate determinants of prolonged viral RNA shedding in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant infection. Materials and methods Hospitalized patients tested SARS-CoV-2 positive by nasopharyngeal real-time reverse transcriptase-polymerase chain reaction (RT-PCR) were included in the single-center, retrospective study. Patients were divided into 2 groups according to the timing of viral clearance (≤ 8 days, “early clearance” and ≥15 days, “late clearance”). Results 4,084 patients were included in the study (1,023 late clearance, 3,061 early clearance), with median age of 50 years and a higher proportion (61.4%) of male. Univariate analyses showed that comorbidities (including hypertension, diabetes, and coronary heart disease), receiving vaccine, the number of vaccinations, cycle threshold (Ct) open reading frame 1ab (ORF 1ab), and nucleocapsid protein (N) gene values on admission were associated with late viral clearance. In the multivariable analysis, the number of vaccinations (P = 0.010) and Ct ORF 1ab gene (P < 0.001) values on admission were significantly associated with late viral clearance. Generalized Estimating Equations (GEE) analysis showed that the Ct value of ORF 1ab gene and N gene remained unchanged within 3 days, and showed progressively higher values with increasing days during late viral RNA clearance. Conclusion The number of vaccinations and Ct values of ORF 1ab gene were independently associated with a prolonged SARS-CoV-2 RNA shedding.

[1]  Yong Wei,et al.  Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  Guoliang Zhang,et al.  Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule. , 2022, Bioscience trends.

[3]  G. Bálint,et al.  Omicron: increased transmissibility and decreased pathogenicity , 2022, Signal Transduction and Targeted Therapy.

[4]  R. Paton,et al.  The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England , 2022, Science Translational Medicine.

[5]  Wenhong Zhang,et al.  Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic , 2022, The Lancet.

[6]  Kaijin Xu,et al.  Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load , 2022, Infection and drug resistance.

[7]  T. Kanno,et al.  Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees , 2022, Emerging infectious diseases.

[8]  C. Hong,et al.  Factors associated with prolonged viral detection in asymptomatic and mildly symptomatic patients with SARS-CoV-2 infection. , 2022, Journal of infection in developing countries.

[9]  M. Mercado,et al.  Prolonged SARS-CoV-2 nucleic acid conversion time in military personnel outbreaks with presence of specific IgG antibodies , 2022, Journal of Medical Microbiology.

[10]  Saniya M. Ansari,et al.  Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective , 2021, Journal of medical virology.

[11]  G. Cheng,et al.  Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa , 2021, Journal of medical virology.

[12]  Meichun Deng,et al.  Asymptomatic COVID-19 infection: diagnosis, transmission, population characteristics , 2021, BMJ Supportive & Palliative Care.

[13]  W. Dhouib,et al.  Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19 , 2021, International Journal of Infectious Diseases.

[14]  O. Turriziani,et al.  Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection , 2021, Diagnostic Microbiology and Infectious Disease.

[15]  M. Hossain,et al.  Prolonged Viral Shedding in Patients with Mild to Moderate COVID-19 Disease: A Regional Perspective , 2021, Infectious diseases.

[16]  J. Zulueta,et al.  Chronic rhinosinusitis is associated with prolonged SARS‐CoV‐2 RNA shedding in upper respiratory tract samples: A case‐control study , 2020, Journal of internal medicine.

[17]  P. Giorgi Rossi,et al.  Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: a population-based prospective cohort study in Reggio Emilia, Italy , 2020, BMJ Open.

[18]  A. Carmo,et al.  Clearance and persistence of SARS‐CoV‐2 RNA in patients with COVID‐19 , 2020, Journal of medical virology.

[19]  R. Gao,et al.  Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19 , 2020, Science of The Total Environment.

[20]  Jun Liu,et al.  Factors associated with prolonged viral RNA shedding in patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Charles S. Dela Cruz,et al.  Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection , 2020, American journal of respiratory and critical care medicine.

[22]  Yixiao Lin,et al.  Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients , 2020, Chinese medical journal.

[23]  Quanyi Wang,et al.  Viral load of SARS-CoV-2 in clinical samples , 2020, The Lancet Infectious Diseases.

[24]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[25]  Andres Kasekamp A Regional Perspective , 2000 .